Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Sites”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02642679
What this trial is testing

Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects

Who this might be right for
Split-thickness Skin Graft Donor Sites
Brigham and Women's Hospital 19
Very early researchStudy completedNCT04521569
What this trial is testing

Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

Who this might be right for
Lung Transplant
University of Maryland, Baltimore 47
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Not applicableStudy completedNCT02825862
What this trial is testing

Investigating Affective Attitude Question-behaviour Effects on Intention to Become an Organ Donor

Who this might be right for
Organ Donation
Royal College of Surgeons, Ireland 999
Not applicableStudy completedNCT03567148
What this trial is testing

The Effectiveness of Different Methods for Healing a Palatal Donor Site

Who this might be right for
Wound HealGraft PainPalate; Wound
Gazi University 90
Large-scale testing (Phase 3)Ended earlyNCT02999854
What this trial is testing

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 63
Early research (Phase 1)Study completedNCT00675831
What this trial is testing

Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Not applicableStudy completedNCT04069416
What this trial is testing

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

Who this might be right for
Hcc
Ain Shams University 241
Not applicableEnded earlyNCT05666999
What this trial is testing

Post-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®)

Who this might be right for
Skin Transplantation
UPM-Kymmene Corporation 18
Early research (Phase 1)Study completedNCT02805075
What this trial is testing

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Hematologic Malignancy
Stanford University 15
Not applicableStudy completedNCT04687982
What this trial is testing

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

Who this might be right for
Bone Marrow Transplant InfectionBone Marrow Transplant ComplicationsGraft Vs Host Disease+2 more
Istituto Clinico Humanitas 19
Not applicableStudy completedNCT07196358
What this trial is testing

Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites

Who this might be right for
Hypertrophic ScarringPain, PostoperativeWound Healing
Dr. Ruth K.M. Pfau Civil Hospital, Karachi 400
Early research (Phase 1)UnknownNCT04234750
What this trial is testing

Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites

Who this might be right for
Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites
Chinese PLA General Hospital 20
Not applicableEnrolling By InvitationNCT00001620
What this trial is testing

Screening for Hematology Branch Protocols

Who this might be right for
Hematologic Disease and DisordersDonorsHealthy Volunteer
National Heart, Lung, and Blood Institute (NHLBI) 10,000
Large-scale testing (Phase 3)Ended earlyNCT00539097
What this trial is testing

Evaluation Perioperative Nutrition on Donor Site Healing in Patients Undergoing Reconstructive Burn Surg

Who this might be right for
BurnReconstructive Surgical Procedure
Shriners Hospitals for Children 38
Not applicableNot Yet RecruitingNCT07762989
What this trial is testing

Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon Autograft

Who this might be right for
Anterior Cruciate Ligament InjuryAnterior Cruciate Ligament ReconstructionDonor Site Complication
Gazi University 20
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableStudy completedNCT06459947
What this trial is testing

Effect of Cyanoacrylate and Concentrated Growth Factor on Palatal Donor Site

Who this might be right for
Wound HealingPainPatient Comfort
Yuzuncu Yil University 60
Next Page